title: Role of the interaction between puerarin and the erythrocyte membrane in puerarin-induced hemolysis.
abstract: Adverse drug reactions (ADR), especially intravenous hemolysis, have largely limited the application of puerarin injections in clinics. This study investigated the underlying mechanisms of puerarin-induced hemolysis. Our results show that puerarin induced concentration-dependent and time-dependent hemolysis when human erythrocytes were incubated in saline solution with more than 2mM puerarin for over 2h. However, incubation in PBS or addition of 1mM of lidocaine to the saline solution completely abolished the hemolysis. Providing materials that could start ATP synthesis did not reverse the hemolysis, and puerarin did not affect Na(+)-K(+)-ATPase activity. In addition, puerarin (0.1-2mM) did not cause calcium influx or exhibited pro-oxidant activity in erythrocytes. Puerarin exhibited different influences on the membrane microviscosity of erythrocytes in saline and PBS. Moreover, 1mM lidocaine inhibited 8mM puerarin-induced reduction of membrane microviscosity in saline solution. SDS-PAGE analysis of membrane proteins revealed that 2mM puerarin treatment induced the appearance of several new protein bands but attenuated the expression of protein bands 2.1, 3, 4.1, 4.2 and 5. These results suggest that high concentrations of puerarin-induced hemolysis were associated with the changes of membrane lipids and of the composition of erythrocytes membrane proteins but not with ATP depletion, pro-oxidation and calcium influx. These changes could be related to the intercalation of amphiphilic puerarin at high concentration into the erythrocyte membrane in certain media, resulting in membrane disorganization and, eventually, cytolysis. Hence, in clinics, determining the optimal dose of puerarin is critical to avoid overdosing and ADR.
authors: School of Chinese Pharmaceutical Science, Guangzhou University of Chinese Medicine, University Town, Guangzhou, China.
authors: Shao-Zhen
authors: SZ
authors: Hou
authors: Zi-Ren
authors: ZR
authors: Su
authors: Shu-Xian
authors: SX
authors: Chen
authors: Mu-Rong
authors: MR
authors: Ye
authors: Song
authors: S
authors: Huang
authors: Liang
authors: L
authors: Liu
authors: Hua
authors: H
authors: Zhou
authors: Xiao-Ping
authors: XP
authors: Lai
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000975:Antioxidants / Q000633:toxicity; D002462:Cell Membrane / Q000187:drug effects* / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism; D006461:Hemolysis / Q000187:drug effects*; D053878:Hemolytic Agents / Q000633:toxicity; D006801:Humans; D007529:Isoflavones / Q000633:toxicity*; D008565:Membrane Proteins / Q000378:metabolism; D048789:Phytoestrogens / Q000633:toxicity*; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism
chemical_list: D000975:Antioxidants; D053878:Hemolytic Agents; D007529:Isoflavones; D008565:Membrane Proteins; D048789:Phytoestrogens; D000255:Adenosine Triphosphate; D000254:Sodium-Potassium-Exchanging ATPase; C033607:puerarin